The structure of concomitant diseases in patients with pulmonary tuberculosis with tobacco dependence

Capa

Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

Purpose. The structure of concomitant diseases in patients with pulmonary tuberculosis with tobacco dependence.

Materials and methods. A retrospective cohort study was conducted on the basis of the Department of Phthisiology. The study included 188 patients with pulmonary tuberculosis who were divided into two groups depending on their smoking status: 1st (n=83) – smoking patients; 2nd (n=105) – non-smoking patients.

Results. It was found that concomitant pathology was significantly more common among smokers compared with non-smokers (p <0.001). At the same time, the presence of two or more concomitant diseases is also significantly more common in smoking patients (p = 0.097). In the structure of concomitant diseases, attention is drawn to the fact that type 1 and type 2 diabetes mellitus is significantly more common among smokers (p = 0.032), as well as chronic viral hepatitis C (p = 0.032).

Conclusion. The obtained results show that the course and effectiveness of treatment of patients with pulmonary tuberculosis is influenced by a significant factor in the form of tobacco smoking, as well as a wide range of comorbidities among smokers. The study and search for optimal approaches in the treatment of tobacco dependence, as well as the correction of comorbidities, is an extremely relevant and important direction in modern phthisiology.

Sobre autores

N. Chumovatov

Central Tuberculosis Research Institute

Autor responsável pela correspondência
Email: Necro5412@mail.ru
ORCID ID: 0000-0001-8745-7940
Código SPIN: 7088-5717

Candidate of Medical Sciences

Rússia, Moscow

Bibliografia

  1. Чумоватов Н.В., Комиссарова О.Г. Черных Н.А. Современные подходы к лечению больных туберкулезом с множественной лекарственной устойчивостью с применением новых противотуберкулезных препаратов. Вестник ЦНИИТ. 2023; 7 (1): 5–12 [Chumovatov N.V., Komissarova O.G., Chernyh N.A. Modern approaches to treatment of patients with multi-drug resistant tb using novel TB drugs. CTRI Bulletin. 2023; 7 (1): 5–12 (in Russ.)]. doi: 10.57014/2587-6678-2023-7-1-5-12.
  2. Десять основных причин смерти. Информационный бюллетень. ВОЗ, 2017 [The top 10 causes of death. WHO, 2017 (in Russ.)] URL: https://www.who.int/mediacentre/factsheets/fs310/ru/
  3. Бородулина Е.А., Вахляев М.А., Колесникова А.Т. Факторы риска для здоровья, связанные с использованием электронных сигарет (аналитический обзор). Анализ риска здоровью. 2025; 3: 169–82 [Borodulina E.A., Vaxlyaev M.A., Kolesnikova A.T. Health risk factors associated with use of electronic cigarettes (analytical review). Analiz riska zdorov`yu. 2025; 3: 169–82 (in Russ.)] doi: 10.21668/health.risk/2025.3.17
  4. Gegia M., Magee M.J., Kempker R.R. et al. Tobacco smoking and tuberculosis treatment outcomes: a prospective cohort study in Georgia. Bull World Health Organ. 2015; 93 (6): 390–9. doi: 10.2471/BLT.14.147439
  5. Safa M., Tabarsi P., Sharifi H. Pattern of tobacco consumption among TB patients in a tuberculosis referral center. Tanaffos. 2011; 10 (2): 50–5.
  6. Gambhir H.S., Kaushik R.M., Kaushik R. et al. Tobacco smoking-associated risk for tuberculosis: a case-control study. Int Health. 2010; 2 (3): 216–22. doi: 10.1016/j.inhe.2010.07.001
  7. den Boon S., van Lill S.W., Borgdorff M.W. et al. Association between smoking and tuberculosis infection: a population survey in a high tuberculosis incidence area. Thorax. 2005; 60 (7): 555–67. doi: 10.1136/thx.2004.030924
  8. Mahishale V., Patil B., Lolly M. et al. Prevalence of Smoking and Its Impact on Treatment Outcomes in Newly Diagnosed Pulmonary Tuberculosis Patients: A Hospital-Based Prospective Study. Chonnam Med J. 2015; 51 (2): 86–90. doi: 10.4068/cmj.2015.51.2.86
  9. Chuang H.C., Patil B., Lolly M. et al. Cigarette smoke is a risk factor for severity and treatment outcome in patients with culture-positive tuberculosis. Ther Clin Risk Manag. 2015; 11: 1539–44. doi: 10.2147/TCRM.S87218
  10. Quan D.H., Kwong A.J., Hansbro P.M. et al. No smoke without fire: the impact of cigarette smoking on the immune control of tuberculosis. Eur Respir Rev. 2022; 31 (164): 210–52. doi: 10.1183/16000617.0252-2021
  11. Slama K., Chiang C.Y., Enarson D.A. et al. Tobacco and tuberculosis: a qualitative systematic review and meta-analysis. Int J Tuberc Lung Dis. 2007; 11 (10): 1049–61.
  12. Feldman C., Theron A.J., Cholo M.C. et al. Cigarette Smoking as a Risk Factor for Tuberculosis in Adults: Epidemiology and Aspects of Disease Pathogenesis. Pathogens. 2024; 13 (2): 151. doi: 10.3390/pathogens13020151
  13. Wen C.P., Chan T.C., Chan H.T. et al. The reduction of tuberculosis risks by smoking cessation. BMC Infect Dis. 2010; 10: 156. doi: 10.1186/1471-2334-10-156
  14. Чумоватов Н.В., Антонов Н.С., Сахарова Г.М. и др. Количественная оценка связи табакокурения и туберкулеза легких. Профилактическая медицина. 2022; 25 (1): 48–53 [Chumovatov N.V., Antonov N.S., Saharova G.M. et al. Quantitative assessment of the influence of tobacco smoking on the development and course of tuberculosis. Russian Journal of Preventive Medicine. 2022; 25 (1): 48–53 (in Russ.)]. doi: 10.17116/profmed20222501148
  15. Чумоватов Н.В., Черных Н.А., Комиссарова О.Г. Функциональные нарушения легких у курящих больных с туберкулезом легких. Уральский медицинский журнал. 2024; 23 (5): 43–51 [Chumovatov N.V., Chernyh N.A., Komissarova O.G. Functional lung disorders in smoking patients with pulmonary tuberculosis. Ural Medical Journal. 2024; 23 (5): 43–51 (in Russ.)]. doi: 10.52420/umj.23.5.43
  16. Aryanpur M., Hosseini M., Masjedi M.R. et al. A randomized controlled trial of smoking cessation methods in patients newly-diagnosed with pulmonary tuberculosis. BMC Infect Dis. 2016; 16: 369. doi: 10.1186/s12879-016-1727-4
  17. Siddiqi K., Khan A., Ahmad M. et al. Action to stop smoking in suspected tuberculosis (ASSIST) in Pakistan: a cluster randomized, controlled trial. Ann Intern Med. 2013; 158 (9): 667–75. doi: 10.7326/0003-4819-158-9-201305070-00006
  18. Siddiquea B.N., Islam M.A., Bam T.S. et al. High quit rate among smokers with tuberculosis in a modified smoking cessation programme in Dhaka, Bangladesh. Public Health Action. 2013; 3 (3): 243–6. doi: 10.5588/pha.13.0051
  19. Awaisu A., Nik Mohamed M.H., Mohamad Noordin N. et al. The SCIDOTS Project: evidence of benefits of an integrated tobacco cessation intervention in tuberculosis care on treatment outcomes. Subst Abuse Treat Prev Policy. 2011; 6: 26. doi: 10.1186/1747-597X-6-26
  20. Чумоватов Н.В., Антонов Н.С., Сахарова Г.М. и др. Анализ эффективности отказа от табакокурения у пациентов с туберкулезом легких в условиях стационара. Пульмонология. 2022; 32 (6): 869–75 [Chumovatov N.V., Antonov N.S., Sakharova G.M. et al. Analysis of the effectiveness of smoking cessation in patients with pulmonary tuberculosis in a hospital setting. Pul’monologiya. 2022; 32 (6): 869–75 (in Russ.)]. doi: 10.18093/0869-0189-2022-32-6-869-875
  21. Underner M., Perriot J. Smoking and tuberculosis. Presse Med. 2012; 41 (12 Pt 1): 1171–80. doi: 10.1016/j.lpm.2012.02.037
  22. Basnet R., Hinderaker S.G., Enarson D. et al. Delay in the diagnosis of tuberculosis in Nepal. BMC Public Health. 2009; 9: 236. doi: 10.1186/1471-2458-9-236
  23. Adegbite B.R., Edoa J.R., Achimi Agbo P. et al. Epidemiological, Mycobacteriological, and Clinical Characteristics of Smoking Pulmonary Tuberculosis Patients, in Lambaréné, Gabon: A Cross-Sectional Study. Am J Trop Med Hyg. 2020; 103 (6): 2501–5. doi: 10.4269/ajtmh.20-0424.
  24. Lin Y., Dlodlo R.A., Shu Q. et al. Outcomes of a smoking cessation intervention at follow-up after 5 years among tuberculosis patients in China. Tob Induc Dis. 2019; 17: 69. doi: 10.18332/tid/111539
  25. Bates M.N., Khalakdina A., Pai M. et al. Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis. Arch Intern Med. 2007; 167 (4): 335–42. doi: 10.1001/archinte.167.4.335

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).